Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Investigational-Fda'
Investigational-Fda published presentations and documents on DocSlides.
FDA’s Access Mechanisms
by roxanne
When They Work – When They Don’t . And Why. St...
Expanded Access Use of for Investigational Drugs in VA: Focus on COVID-19
by summer
Office of Research Protections, Policy, & Educ...
Preparing for an FDA Inspection
by felicity
. Kathy Gilmartin, MSN, CRNP, CCRC. ...
Preparing for an FDA Inspection
by min-jolicoeur
. Kathy Gilmartin, MSN, CRN...
Preparing for an FDA Inspection
by tawny-fly
. Kathy Gilmartin, MSN, CRN...
1 King & Spalding May 22, 2014
by marina-yarberry
1 King & Spalding ...
Introduction to Research Pharmacy
by trish-goza
Investigational Drug Control and . Patient Safety...
Joint work with many colleagues at FDA
by sandsomber
precision.fda.gov | precisionFDA@fda.hhs.gov | @pr...
FDA Foreign Priorities, Inspections and Compliance
by karlyn-bohler
Bruce Ross. , . M.A. M.P.H.. Director, India Offi...
Emergency use of a test article / treatment use of investigational drugs
by thomas
Emergency use is different than. Expanded Access (...
Writing and Holding an IND- IIT Development
by osullivan
Week 3- Proposing and Conducting a Clinical Trial....
x0000x0000 USA IRB Policy and Procedurex0000x0000Page of
by elena
USA IRB Policy and Procedure...
Proposed Device Use NOT Under an FDA IDE
by priscilla
A compassionate use request for a single patient m...
Compassionate Use Navigator
by delcy
-- www.kidsvcancer.org 1 Contact: Elena Gerasimov,...
Information Sheet Guidance for Institutional Review Boards Clinical I
by anastasia
http://www.fda.gov/ScienceResearch/SpecialTopics/R...
IND Determinations An IRB
by molly
Infoshort. August 2013. IND. An Investigational Ne...
Guidance for Clinical Investigators Sponsors and Investigational New D
by jade
NOTE A stay is in effect for partsof subsection V...
Clinical and Nonclinical Inspections
by claire
n and Research or CBER conducting clinical resear...
UC DAVIS OFFICE OF RESEARCH
by olivia-moreira
Overview of Good Clinical Practices (GCP) . Inves...
IND Determinations
by debby-jeon
An IRB . Infoshort. August 2013. IND. An Investig...
IND Determinations
by lindy-dunigan
An IRB . Infoshort. August 2013. IND. An Investig...
System Treatment Chronic Feferberg Israeli Intelligence Development
by jensen
Improving the health and . well-being of sufferers...
Ebola Virus Disease and
by lam
Clinical Care. Part III. : . Experimental Treatmen...
HRS 2012 S-ICD Clinical Highlights
by WiseWolf
Disclaimer. The content in this presentation was p...
Loxo Oncology Expanded Access Program (EAP)
by undialto
EAP Request Details - To be completed Requester Co...
Best Practices in the Identification and Management of Alzheimer Agitation
by tatiana-dople
Introduction. Effects of AD Agitation. Agitation ...
IP Accountability in
by mitsue-stanley
Outpatient Clinical Trials. Jessica Rinaldi, CCRP...
IP Accountability in
by calandra-battersby
Outpatient Clinical Trials. Jessica Rinaldi, CCRP...
Stephen A. Bean, PharmD
by lois-ondreau
Investigational Drug Service. Department of Pharm...
What is FDA
by adriel473
. FDA. 10. The . Food . and . Drug . Administratio...
ROMA – Overview and FDA Lessons
by tristan742
Clinical Situation: . A woman with a pelvic mass. ...
FDA Regulatory Requirements for Successful Biomarker Applications
by oliver
Early Detection Research Network. September 9, 201...
An Update on FDA Regulations: E-Cigarettes &
by lucinda
Vaping. Deborah J. Ossip, PhD. Professor and Direc...
Pharmacometrics and Biostatistics Interactions at the FDA
by byrne
Jeffry Florian, Ph.D.. Division of Pharmacometrics...
The FDA is Coming Neala Lane, MS, CCRC
by joy
Associate Director. Quality Improvement Office. Of...
FDA Center for Veterinary Medicine
by smith
2022 Update. COSDA Annual Conference. October 2, 2...
FDA Pre-Submission Meetings
by violet
for 510(k) Submissions. Consultants and RA Experts...
FDA Basics 21 CRF 50 –Protection of Human Subjects
by caroline
21 CFR 56 - IRBs. 21 CFR 312 - Drugs. 21 CFR 812 â...
Food and Drug Administration FDA
by wang
9/21 Page 1 Commissioner : J anet Woodcock, M.D. ...
WiFl body scale HS5 FDA 510k Files FDA 510k Files a0aox
by faith
510(k) Summary JUL 2 62012 This summary of 510(k) ...
Load More...